id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-E-2617-0007,FDA,FDA-2018-E-2617,Letter to Wilmer Cutler Pickering Hale and Dorr LLP  from United States Patent and Trademark Office,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T18:17:49Z,,0,0,0900006484c1019e